Botulinum Toxin Market (By Product: Botulinum Toxin Type B, Botulinum Toxin Type A; By End Use: Therapeutics, Aesthetic) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 190

According to Acumen Research and Consulting, the global Botulinum Toxin market is expected to grow at noteworthy CAGR around 8 % throughout the forecast period and reach around US$ 7.5 billion by 2026.

The imperative quality needs and fresh apps are sustaining competition in the worldwide industry of botulinum toxins. Most businesses invest in studies to identify fresh apps which can assist them achieve a higher share and benefit from the worldwide market for botulinum toxins. In addition, the need for high quality requires businesses to implement quality control methods in view of present product apps.

The report provides analysis of global Botulinum Toxin market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.

Market Dynamics

Creating a growing population between the ages of 25 and 65 and growing demand for minimally invasive or non-invasive processes are key drivers of world market growth.

BNT is a neurotoxin that is generated in the anaerobic plant, Clostridium Botulinum, with seven distinct types of antigens, namely BNT- a, B, C, D, E, F and G. For esthetic applications, BNT is used extensively. Currently there are commercially available a few BNT-A and just one BNT-B products on the market. However, heavy research & development investments to develop botulinum toxin therapeutic use create possibilities in the near future to expand its scope of use.

Neurotoxins, in addition to cosmetic applications, are hindered by side effects such as allergic reactions, rash, neck and back pain, trouble swallowing, short-sightedness and nausea. Furthermore, high costs for the performance of such costly processes and bad reimbursement coverage by Solstice Neurosciences, LLC for products such as Myobloc further hinder the development of the industry.

Product Outlook

With the biggest share in 2015, the BNTA segment is leading the worldwide market. During the forecast period, this segment is to continue to dominate. Diverse BNTA goods, including major brands such as Botox and Dysport, are commercially accessible on the market. Botox has esthetic implementation in the removal and therapeutic treatments of serious axillary main hyperidrosis and blepharospasm and cervical dystonia, with mild and severe glabelar lines. Xeomin is also used in certain nations to remove glabellar lines and treat cervical dystonia and blepharospasm. However, there are few side effects, including allergic responses, nausea, rash, neck and back pain, that have been noted. Products from BNTA also cost a great deal and cost a lot during operations. Therefore, these variables hamper market growth.

Application Stance

Toxin botulinum is used mainly to enhance facial appearance and to reduce signs of aging in cosmetic (esthetic) applications. The frown lines, crow's foot and glabellar lines are to be treated. This led to a greater market share of the esthetic segment in 2015.

Allergan got the U.S. botulinum toxin (Botox) Approval of FDA in 2004 for hyperhidrosis, cervical dystonia in 2009, post-strokes spasticity for the upper limb in 2010 and overactive bladder and urinary incontinence in 2011. It is thus noted that the Botox use is expanded through multiple signs through consistent R&D attempts.

Furthermore, other products, such as dysport and xeomin, are used to treat blepharospasm and hyperidrose. Myobloc is also used for the treatment of cervical dystonia, a botulinum toxin B (BNTB), which is commercially accessible under the brand name. Given the ever increasing use of botulinum toxin in therapeutic apps, therapeutic applications are expected to increase considerably during the predicted period.

Therapeutic applications of botulinum toxin in cosmetic apps that pave the way for additional development in the application field

While botulinum toxin is believed to be used mainly for the treatment of cosmetic diseases, the therapeutic application is far more than cosmetic. For chronic migraine, muscle spast, reagent bladder, and hyperhidrosis cases, botulinum toxin is an efficient therapy alternative. In addition, in females with endometriosis, botulinum toxin has been discovered to be highly efficient in alleviating chronic instances of pelvic pain. Studies show that botulinum toxin injected patients have been able to remain free for up to 11 months. In cosmetic applications such as forehead lines, crown feet, square jaw / masseter brown lines / bellar, and others, botulinum toxin is also commonly used. botulinum toxin is also used. The therapeutic industry, however, is anticipated to grow rapidly and the demand for botulinum toxin in muscle spasm treatment in the coming years is projected to increase exponentially.

Botulinum toxin has been shown to treat invasive diseases like fasciitis

Fasciitis necrotizing is an uncommon type of fatal illness that is consumed in human beings and may harm human life if not properly diagnosed and handled instantly. This skin disease spreads rapidly across the body because of a number of bacterial strains and diminishes the capacity of the body to efficiently combat infection. New studies have shown that the administration of botulinum toxin to Necrotized Fasciitis patients helps to block nerve signals and control the infection's spread. In the course of fresh research and innovation studies, the role of botulinum toxin in treatment of chronic diseases is expected to increase market growth.

Regional Stance

By gaining the biggest share of sales in 2015, North America dominated the market. The demand for botulinum toxin in North America has increased disposable revenues and a range of esthetic processes for increasing external appearance.

Asia Pacific is anticipated to grow most soon as demographics and disposable income grow older and the demand for anti-aging products rises. Moreover, a increasing social awareness of the market accessibility of these goods in Asia Pacific is expected to increase market development in the near future.

Market Segmentation

Global Botulinum Toxin Market, By Product

  • Botulinum Toxin Type B
  • Botulinum Toxin Type A

Global Botulinum Toxin Market, By End Use

  • Therapeutics
  • Aesthetic

Global Botulinum Toxin Market, By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

The market research study on “Botulinum Toxin Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Botulinum Toxin market segments with market dynamics and their impact. The report also covers basic technology development policies.

The report provides an analysis of the latest trends and opportunities in each of the sub-segment from 2015 to 2026 and forecasts revenue growth in the global, regional and country levels. ARC has divided the botulinum toxin market by product, end usage and region for this research.

Our reports are one-point solutions for the growth, development and maturity of companies. Our information collection techniques in real time, together with the capacity to track over a million high-growth niche products, meet your goals. In order for our analysts to make correct decisions, the detailed and proprietary statistical models are used in the shortest period of time. We deliver tailored alternatives through ad-hoc reports for organisations that need particular but thorough data. These applications have the perfect combination of the correct sense of fact-oriented methodologies for issue solving and leveraging current repositories.

Key Players & Strategies

The main business players are The Ipsen Group ; Allergan, Inc.; Merz Pharma GmbH and Co. These businesses have a powerful world market position, primarily owing to their powerful brand image and accessibility worldwide.

Other market players include US Worldmed, LLC; Medytox, Inc.; Lanzhou Biological Products Institute Co. Ltd., and Therapeutics Revance, Inc. The market competition is anticipated to increase in the near future as various businesses now concentrate on their study efforts to introduce new therapeutic applications of the current products.


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary